What was Stem Cell Authority’s price range in the past 12 months?
Stem Cell Authority lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.
What is Stem Cell Authority’s market cap?
Stem Cell Authority’s market cap is $2.44M.
When is Stem Cell Authority’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Stem Cell Authority overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Stem Cell Authority pay dividends?
Stem Cell Authority does not currently pay dividends.
What is Stem Cell Authority’s EPS estimate?
Stem Cell Authority’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stem Cell Authority have?
Stem Cell Authority has 12,180,000,000 shares outstanding.
Which hedge fund is a major shareholder of Stem Cell Authority?
Currently, no hedge funds are holding shares in SCAL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stem Cell Authority
Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced from umbilical cord blood, and "Miracle Mesenchymal" stem cells, derived from the Wharton's jelly found within a newborn's umbilical cord. SCAL provides healthcare professionals involved in childbirth throughout the United States with advanced technology to offer these vital stem cell preservation services to their maternity patients. The company's operations are based in Fairlawn, Ohio.